Transplant-associated SCC (TSCC) patients showed decreased CD8+ T effector cells (p < 0.05) and demonstrated an increased frequency (>6 fold) of primary cSCC [74]. The gene discussed is CD8A; the disease is skin squamous cell carcinoma.